ArticleInvestigational new drugs2015

Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors.

Shinji Nakamichi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.